ArticleFrontiers in pharmacology2017

SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis.

Shuang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.